SCHEMBL13065613

SCHEMBL13065613

CCN(CC)c1ccc2nc3c(C(=O)O)c(-c4cccc(OC)c4)c(=O)c(OC)c-3oc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
NPC1 O15118 1/20 0.42
POLB P06746 1/20 0.42
RAB9A P51151 1/20 0.42
SCP2 P22307 1/20 0.41
GPR35 Q9HC97 1/20 0.39
GPR84 Q9NQS5 6/20 0.38
CFTR P13569 1/20 0.38
KDM4E B2RXH2 5/20 0.37
HPGD P15428 5/20 0.37
ALDH1A1 P00352 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.37
RXRA P19793 1/20 0.37
RXRB P28702 1/20 0.37
HSD17B10 Q99714 4/20 0.37
MAPT P10636 4/20 0.37
CYP3A4 P08684 3/20 0.37
CYP2D6 P10635 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065600 0.92 MEN1 (0.47) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL13065603 0.92 MAPT (0.42) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL13065602 0.91 SCP2 (0.44) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL16784714 0.91 GPR35 (0.41) MEN1KMT2ANPC1RAB9AGPR35
SCHEMBL13065604 0.87 MEN1 (0.41) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL13065624 0.87 DHODH (0.42) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL13065593 0.87 MEN1 (0.41) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL13065588 0.86 MEN1 (0.41) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL13065606 0.85 SCP2 (0.41) MEN1KMT2ANPC1POLBRAB9A
SCHEMBL13065742 0.85 KDM4E (0.47) MEN1KMT2AGPR35KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 MEN1 3364/4885KMT2A 4381/4885NPC1 2196/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 MEN1 3364/4885KMT2A 4381/4885NPC1 2196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.